Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong
· Delayed Price · Currency is HKD 5.13
+0.03 (0.59%)
Jun 9, 2025, 4:08 PM HKT
Lepu Biopharma Revenue
In the year 2024, Lepu Biopharma had annual revenue of 367.79M CNY with 63.21% growth. Lepu Biopharma had revenue of 234.51M in the half year ending December 31, 2024, with 1,405.98% growth.
Revenue
367.79M CNY
Revenue Growth
+63.21%
P/S Ratio
22.29
Revenue / Employee
738.54K CNY
Employees
498
Market Cap
8.72B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 28.99B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |